DONGSUN GPHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 002210 for the last quarter is 21.74 B KRW, and it's 4.27% lower compared to the previous quarter. The net income of Q2 24 is -1.06 B KRW.